![PRD_000922 PRD_000922](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000922.svg) | PRD_000922 | Name: | PL-42 | Formula: | C39 H63 N9 O14 P S | Definition date: | 2013-04-03 | Last modified: | 2013-06-03 |
|
![PRD_000924 PRD_000924](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000924.svg) | PRD_000924 | Name: | Ac-DEVD-CMK | Formula: | C21 H33 Cl N4 O11 | Definition date: | 2013-05-08 | Last modified: | 2013-06-03 |
|
![PRD_000937 PRD_000937](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000937.svg) | PRD_000937 | Name: | peptide inhibitor | Formula: | C33 H50 N4 O9 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000940 PRD_000940](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000940.svg) | PRD_000940 | Name: | D-PHE-PRO-D-ARG-D-THR DERIVED DIRECT THROMBIN INHIBITOR | Formula: | C24 H39 N8 O5 | Definition date: | 2013-04-17 | Last modified: | 2013-06-03 |
|
![PRD_000941 PRD_000941](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000941.svg) | PRD_000941 | Name: | [Aba5,14]BTD-2 | Formula: | C80 H150 N36 O18 S4 | Definition date: | 2013-02-27 | Last modified: | 2013-06-03 |
|
![PRD_000184 PRD_000184](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000184.svg) | PRD_000184 | Name: | Microcin J25 | Formula: | C101 H140 N23 O27 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000960 PRD_000960](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000960.svg) | PRD_000960 | Name: | N-[(benzyloxy)carbonyl]-L-valyl-L-alpha-glutamyl-N-[(2R)-1-carboxy-3-oxo-4-(2,3,5,6-tetrafluorophenoxy)butan-2-yl]-L-isoleucinamide | Formula: | C35 H42 F4 N4 O11 | Definition date: | 2013-03-20 | Last modified: | 2013-06-03 |
|
![PRD_000966 PRD_000966](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000966.svg) | PRD_000966 | Name: | [(5S)-5-[[(2S)-6-azaniumyl-2-[[(2S)-6-azaniumyl-2-[2-[[(2S)-2-[[(2S)-2-[[(2S,5S,8S,11S,20S)-20-[[(2S)-2-[[(2S,3R)-2-[[(2S,3S)-2-azanyl-3-methyl-pentanoyl]amino]-3-oxidanyl-butanoyl]amino]-3-phenyl-propanoyl]amino]-2-(2-hydroxy-2-oxoethyl)-11,20-dimethyl-5,8-bis(2-methylpropyl)-3,6,9,21-tetrakis(oxidanylidene)-1,4,7,10-tetrazacyclohenicos-11-yl]carbonylamino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]ethanoylamino]hexanoyl]amino]hexanoyl]amino]-6-oxidanyl-6-oxidanylidene-hexyl]azanium | Formula: | C87 H140 N17 O20 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000976 PRD_000976](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000976.svg) | PRD_000976 | Name: | N-acetyl-L-valyl-L-alpha-glutamyl-N-[(2S)-1-carboxy-3-oxopropan-2-yl]-L-isoleucinamide | Formula: | C22 H36 N4 O9 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000977 PRD_000977](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000977.svg) | PRD_000977 | Name: | 1-acetyl-L-prolyl-L-threonyl-N-[(2R,3S)-4-chloro-3-hydroxy-1-(4-hydroxyphenyl)butan-2-yl]-L-serinamide | Formula: | C24 H35 Cl N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000989 PRD_000989](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000989.svg) | PRD_000989 | Name: | ISOAMYLPHOSPHONYL-GLY-PRO-ALA | Formula: | C15 H28 N3 O6 P | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000997 PRD_000997](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000997.svg) | PRD_000997 | Name: | JTH-NB72-39 | Formula: | C42 H74 N14 O9 S | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000998 PRD_000998](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000998.svg) | PRD_000998 | Name: | [Aba3,16]BTD-2 | Formula: | C80 H150 N36 O18 S4 | Definition date: | 2013-02-27 | Last modified: | 2013-06-03 |
|
![PRD_000999 PRD_000999](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000999.svg) | PRD_000999 | Name: | ALPHA-BETA-FOLDAMER 2C | Formula: | C110 H166 N28 O28 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_001002 PRD_001002](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001002.svg) | PRD_001002 | Name: | [Aba3,7,12,16]BTD-2 | Formula: | C82 H156 N36 O18 S2 | Definition date: | 2013-02-27 | Last modified: | 2013-06-03 |
|
![PRD_001006 PRD_001006](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001006.svg) | PRD_001006 | Name: | [Aba5,7,12,14]BTD-2 | Formula: | C82 H156 N36 O18 S2 | Definition date: | 2013-02-27 | Last modified: | 2013-06-03 |
|
![PRD_001009 PRD_001009](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001009.svg) | PRD_001009 | Name: | [Aba3,5,7,12,14,16]BTD-2 | Formula: | C84 H162 N36 O18 | Definition date: | 2013-02-27 | Last modified: | 2013-06-03 |
|
![PRD_001013 PRD_001013](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001013.svg) | PRD_001013 | Name: | Peptide Inhibitor (ACE)ADVAD-CHO | Formula: | C21 H33 N5 O10 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_001014 PRD_001014](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001014.svg) | PRD_001014 | Name: | APO-monomer | Formula: | C115 H198 N39 O24 | Definition date: | 2013-04-17 | Last modified: | 2013-06-03 |
|
![PRD_001020 PRD_001020](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001020.svg) | PRD_001020 | Name: | GDC0152 | Formula: | C25 H34 N6 O3 S | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_001030 PRD_001030](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001030.svg) | PRD_001030 | Name: | ACE-PHE-GLU-LYS-ALA chloromethylketone INHIBITOR | Formula: | C26 H41 Cl N5 O7 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_001039 PRD_001039](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001039.svg) | PRD_001039 | Name: | BICYCLIC PEPTIDE INHIBITOR UK504 | Formula: | C55 H94 N23 O16 S4 | Definition date: | 2013-05-15 | Last modified: | 2013-06-03 |
|
![PRD_001045 PRD_001045](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001045.svg) | PRD_001045 | Name: | TMC-95A mimic ligand yCP:4a chain P | Formula: | C43 H47 N5 O9 | Definition date: | 2013-05-01 | Last modified: | 2013-06-03 |
|
![PRD_001048 PRD_001048](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001048.svg) | PRD_001048 | Name: | N-acetyl-L-valyl-L-alpha-aspartyl-L-valyl-N-[(2R)-1-carboxy-3-oxopropan-2-yl]-L-alaninamide | Formula: | C23 H37 N5 O10 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_001052 PRD_001052](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001052.svg) | PRD_001052 | Name: | N-acetyl-L-alpha-aspartyl-L-valyl-N-[(2S)-1-carboxy-3-oxopropan-2-yl]-L-alaninamide | Formula: | C18 H28 N4 O9 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|